Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KLK7 | P49862 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6879887 | 1.00 | LMNA (0.40) | LMNAALDH1A1TSHRKLK7 | |
| SCHEMBL5356462 | 1.00 | LMNA (0.40) | LMNAALDH1A1TSHRKLK7 | |
| SCHEMBL9191546 | 0.92 | LMNA (0.40) | LMNA | |
| SCHEMBL22661219 | 0.92 | LMNA (0.34) | LMNAALDH1A1 | |
| SCHEMBL25813346 | 0.89 | LMNA (0.35) | LMNA | |
| SCHEMBL14181569 | 0.88 | LMNA (0.41) | LMNAALDH1A1TSHRKLK7 | |
| SCHEMBL9260881 | 0.87 | LMNA (0.62) | LMNA | |
| SCHEMBL9353070 | 0.87 | LMNA (0.42) | LMNA | |
| SCHEMBL8978138 | 0.87 | LMNA (0.62) | LMNA | |
| SCHEMBL7581413 | 0.86 | LMNA (0.42) | LMNATSHRKLK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2723709-B1 | MANUFACTURE OF A TRIIODINATED CONTRAST AGENT | HOVIONE INT LTD (CH) | 2015-09-09 | — | — | EP | claimed |
| US-8835672-B2 | Manufacture of a triiodinated contrast agent | HOVIONE INTER LIMITED (CH) | 2014-09-16 | — | — | US | claimed |
| US-20140155648-A1 | Manufacture of a Triiodinated Contrast Agent | HOVIONE INTER LIMITED (CH) | 2014-06-05 | — | — | US | claimed |
| EP-1075462-B1 | PROCESS FOR THE PREPARATION OF S- N,N'- BIS[2- HYDROXY-1- (HYDROXYMETHYL) ETHYL]-5- [(2- HYDROXY-1- OXOPROPYL)- AMINO]- 2,4,6- TRIIODO- 1,3- BENZENEDICARBOXAMIDE | BRACCO IMAGING SPA (IT) | 2003-06-25 | — | — | EP | claimed |
| EP-1112247-B1 | A PROCESS FOR THE PREPARATION OF S-N,N'-BIS 2-HYDROXY-1- (HYDROXYMETHYL) ETHYL]-5- (2-HYDROXY-1- OXOPROPYL) AMINO]-2,4,6- TRIIODO-1,3- BENZENEDICARBOXAMIDE | BRACCO IMAGING SPA (IT) | 2003-04-16 | — | — | EP | claimed |
| EP-0901460-B1 | A PROCESS FOR THE PREPARATION OF 5-AMINO-2,4,6-TRIIODO-1,3-BENZENEDICARBOXYLIC ACID DERIVATIVES | BRACCO IMAGING SPA (IT) | 2002-09-18 | — | — | EP | claimed |
| US-6350908-B1 | MULTISTAGE REACTION WITH AMIDATION OF ACYL HALIDES WITH AMINOALKANEDIOLS AND HYDROLYSIS | BRACCO IMAGING S.P.A (IT) | 2002-02-26 | — | — | US | claimed |
| EP-0851854-B1 | PROCESS FOR THE PURIFICATION OF AN INTERMEDIATE IN THE PREPARATION OF IOPAMIDOL | BRACCO IMAGING SPA (IT) | 2001-12-12 | — | — | EP | claimed |
| US-6262303-B1 | FROM THE COORRESPONDING DIACID CHLORIDE WITH 2-AMINO-1,3-PROPANEDIOL IN SOLVENT | DIBRA S.P.A. (IT) | 2001-07-17 | — | — | US | claimed |
| EP-1075462-A2 | PROCESS FOR THE PREPARATION OF S- N,N'- BIS[2- HYDROXY-1- (HYDROXYMETHYL) ETHYL]-5- [(2- HYDROXY-1- OXOPROPYL)- AMINO]- 2,4,6- TRIIODO- 1,3- BENZENEDICARBOXAMIDE | BRACCO IMAGING S.p.A. (IT) | 2001-02-14 | — | — | EP | claimed |
| EP-0773925-B1 | PROCESS FOR THE PREPARATION OF A DICARBOXYLIC ACID DICHLORIDE | FRUCTAMINE SPA (IT) | 2000-02-09 | — | — | EP | claimed |
| WO-1999058494-A2 | PROCESS FOR THE PREPARATION OF S- N,N'- BIS[2- HYDROXY-1- (HYDROXYMETHYL) ETHYL]-5- [(2- HYDROXY-1- OXOPROPYL)- AMINO]- 2,4,6- TRIIODO- 1,3- BENZENEDICARBOXAMIDE | DIBRA S.P.A. (IT) | 1999-11-18 | — | — | WO | claimed |
| WO-2023117667-A1 | PROCESS FOR THE PREPARATION OF 2,4,6-TRIIODOISOPHTHALIC BISAMIDES | BRACCO IMAGING SPA (IT) | 2023-06-29 | — | — | WO | disclosed |
| EP-3580199-B1 | METHOD FOR THE ONE-POT PRODUCTION OF ORGANO-IODINATED COMPOUNDS | GUERBET SA (FR) | 2023-04-05 | — | — | EP | disclosed |
| US-10836711-B2 | Method for the one-pot production of organo-iodinated compounds | GUERBET (FR) | 2020-11-17 | — | — | US | disclosed |
| US-10738000-B2 | Method for the preparation of (S)-2-acetyloxypropionic acid and derivatives thereof | BRACCO IMAGING SPA (IT) | 2020-08-11 | — | — | US | disclosed |
| WO-1996037460-A1 | PROCESS FOR THE PREPARATION OF A DICARBOXYLIC ACID DICHLORIDE | FRUCTAMINE S.P.A. (IT) | 1996-11-28 | — | — | WO | disclosed |
| EP-0707572-A1 | IODINATED OLIGOMERIC COMPOUNDS AND DIAGNOSTIC COMPOSITIONS CONTAINING THE SAME | BRACCO S.p.A. (IT) | 1996-04-24 | — | — | EP | disclosed |
| WO-1995001966-A1 | IODINATED OLIGOMERIC COMPOUNDS AND DIAGNOSTIC COMPOSITIONS CONTAINING THE SAME | BRACCO S.P.A. (IT) | 1995-01-19 | — | — | WO | disclosed |
| US-4364921-A | RADIOPACITY | SCHERING, AKTIENGESELLSCHAFT (DE) | 1982-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10836711-B2 | Method for the one-pot production of organo-iodinated compounds | TPO, NISCH, PPIP5K2 | LMNA 3525/4885ALDH1A1 2138/4885TSHR 57/4885 |
| US-10738000-B2 | Method for the preparation of (S)-2-acetyloxypropionic acid and derivatives thereof | LDHA, ACACA, ADSL | LMNA 467/4885ALDH1A1 50/4885TSHR 3843/4885 |
| US-20140155648-A1 | Manufacture of a Triiodinated Contrast Agent | SAT1, LYPLA2, AGPAT5 | LMNA 2871/4885ALDH1A1 319/4885TSHR 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.